RE: Consolidated Billing Scenario

[Brenda Chance]

I would say he probably receives tobramycin on dialysis due him receiving the dose during filtering which ensures that the body can optimally use the medication.  A lot of IV antibiotics that can cause worsening of renal disease are given during this time to prevent complications and to ensure that the resident is responding to the antibiotic.  I hope that this makes sense.  It is difficult to explain.   Brenda W. Chance, RN, RAC-C MDS Coordinator     CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. -----Original Message----- From: Jan[EMAIL PROTECTED] [mailto:Jan[EMAIL PROTECTED] Sent: Wednesday, October 29, 2003 10:19 AM To: [EMAIL PROTECTED] Subject: Re: Consolidated Billing Scenario   Ron,    Interesting scenario. If the resident is not getting the Med for ESRD and it's not excluded from CB, then why don't you admister at the facility and take the credit for it? Not a very good answer, but wondering with you!!! Okay billing Guru's--what's the answer? Jan     In a message dated 10/27/2003 2:39:50 PM Eastern Standard Time, [EMAIL PROTECTED] writes: Resident goes out to dialysis 3x/wk and receives tobramycin IV while at dialysis.  Facility currently sends the IV medication with the resident for the dialysis center to administer.  We know that we cannot take credit for it on the MDS. The tobramycin is not related to the ESRD diagnosis.  My first thought was to have the dialysis center supply AND administer the drug.  However, since tobramycin is not excluded from CB, could the dialysis center bill for this or would the SNF still be responsible.  I am thinking the facility is responsible since it is unrelated to the dialysis but may be wrong. Any thoughts? Thanks Ron